Literature DB >> 9162010

Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis.

J T Belisle1, V D Vissa, T Sievert, K Takayama, P J Brennan, G S Besra.   

Abstract

The dominant exported proteins and protective antigens of Mycobacterium tuberculosis are a triad of related gene products called the antigen 85 (Ag85) complex. Each has also been implicated in disease pathogenesis through its fibronectin-binding capacities. A carboxylesterase domain was found within the amino acid sequences of Ag85A, B, and C, and each protein acted as a mycolyltransferase involved in the final stages of mycobacterial cell wall assembly, as shown by direct enzyme assay and site-directed mutagenesis. Furthermore, the use of an antagonist (6-azido-6-deoxy-alpha, alpha'-trehalose) of this activity demonstrates that these proteins are essential and potential targets for new antimycobacterial drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9162010     DOI: 10.1126/science.276.5317.1420

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  254 in total

1.  Boosting vaccine for tuberculosis.

Authors:  J V Brooks; A A Frank; M A Keen; J T Bellisle; I M Orme
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Conditional sigma factor expression, using the inducible acetamidase promoter, reveals that the Mycobacterium tuberculosis sigF gene modulates expression of the 16-kilodalton alpha-crystallin homologue.

Authors:  Y C Manabe; J M Chen; C G Ko; P Chen; W R Bishai
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

3.  Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.

Authors:  J Turner; E R Rhoades; M Keen; J T Belisle; A A Frank; I M Orme
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs.

Authors:  B Y Lee; M A Horwitz
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Antigen specificity of T-cell response to Mycobacterium avium infection in mice.

Authors:  T F Pais; J F Cunha; R Appelberg
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis.

Authors:  L E Desjardin; L G Hayes; C D Sohaskey; L G Wayne; K D Eisenach
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

7.  New virulence-activated and virulence-repressed genes identified by systematic gene inactivation and generation of transcriptional fusions in Bordetella pertussis.

Authors:  R Antoine; S Alonso; D Raze; L Coutte; S Lesjean; E Willery; C Locht; F Jacob-Dubuisson
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

8.  Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.

Authors:  Natalie A Parlane; Katrin Grage; Jun Mifune; Randall J Basaraba; D Neil Wedlock; Bernd H A Rehm; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

9.  Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.

Authors:  M A Horwitz; G Harth; B J Dillon; S Maslesa-Galic'
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

10.  Photoactivatable Glycolipid Probes for Identifying Mycolate-Protein Interactions in Live Mycobacteria.

Authors:  Herbert W Kavunja; Kyle J Biegas; Nicholas Banahene; Jessica A Stewart; Brent F Piligian; Jessica M Groenevelt; Caralyn E Sein; Yasu S Morita; Michael Niederweis; M Sloan Siegrist; Benjamin M Swarts
Journal:  J Am Chem Soc       Date:  2020-04-20       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.